hameln rds
EU GMP contract manufacturer of APIs and highly potent APIs, with QC, stability and regulatory services for pharma companies
Highlights
- ProfitableFY2025 net profit €1.2M · RÚZ
About hameln rds
hameln rds is a CDMO based in Modra, Slovakia, offering modular services for active pharmaceutical ingredients: API and HPAPI development and GMP manufacturing, analytical testing and stability studies, sterile injectable formulation development, and regulatory affairs. It also runs environmental risk assessment studies with its partner LAUS GmbH.
The company's customers are pharmaceutical companies that can buy a single development, analytical or manufacturing step or the full process. Each client works with an assigned technical specialist and a project manager. The website lists an API portfolio that includes highly potent analgesic and CNS APIs, including piritramide, which it describes as manufactured solely by it in Europe.
The Drug Research Institute from which the company descends was founded in Hlohovec in 1972 and moved to Modra in 1977. In 2006 hameln rds GmbH acquired VULM a.s., and since 2014 the company has been part of the hameln group, with operations in Slovakia, Germany and the UK. The website states about 140 employees in Modra; at the time of the site text no open positions were listed.
Product: Modular API and HPAPI development and GMP manufacturing, analytical and stability testing, sterile formulation development and regulatory affairs services
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €24.2M | €32.4M | €34.6M | €38.0M | €31.4M |
| Growth | −25% | −7% | −9% | +21% | — |
| EBITDA | €2.7M | €2.3M | €3.2M | €5.6M | €7.0M |
| Operating profit | €1.2M | €768k | €1.7M | €4.1M | €5.6M |
| Net profit | €1.2M | €617k | €1.2M | €3.2M | €4.3M |
| Net margin | 4.9% | 1.9% | 3.4% | 8.4% | 13.8% |
| Personnel costs | €6.4M | €5.3M | €5.4M | €5.2M | €4.7M |
| Total assets | €21.3M | €20.6M | €23.6M | €20.6M | €20.1M |
| Cash | €3.4M | €1.6M | €882k | €653k | €1.3M |
| Liabilities | €3.3M | €3.8M | €7.4M | €5.5M | €8.3M |
| Equity | €18.0M | €16.8M | €16.2M | €15.0M | €11.8M |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts hameln rds signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
8 contracts with 5 buyers · €2k
| Contracts | Value | |
|---|---|---|
| Mesto Modra | 2 | €1k |
| Spojená škola, Pezinok | 1 | €607 |
| Trnavská univerzita so sídlom v Trnave | 2 | €500 |
| Slovenská technická univerzita v Bratislave | 2 | — |
| Chemický ústav Slovenskej akadémie vied, v. v. i. | 1 | — |
Open public tenders for hameln rds →
Suppliers
1 contract with 1 supplier · —
| Contracts | Value | |
|---|---|---|
| Slovenská technická univerzita v Bratislave | 1 | — |
Latest contracts
- 17 Apr 2026 from Slovenská technická univerzita v Bratislave · Rámcová zmluva o dielo č. 27/26 register
- 12 Feb 2026 for Mesto Modra · Darovacia zmluva · €1k register
- 22 Jan 2026 for Trnavská univerzita so sídlom v Trnave · Sponzorská zmluva · €250 register
- 22 Dec 2025 for Mesto Modra · Memorandum o spolupráci register
- 14 Nov 2025 for Spojená škola, Pezinok · Darovacia zmluva · €607 register
- 2 Jun 2025 for Slovenská technická univerzita v Bratislave · Dohoda o zabezpečení a vykonaní odbornej praxe študenta č. 0404/0058/25 register
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in Czechia, worth 1.0M CZK as awarded. From EU award notices (TED) that name hameln rds by its registry number.
- 9 Jul 2024 Ministerstvo obrany · Radioprotektiva · 1.0M CZK notice
Jobs at hameln rds
Leadership
- Marian Takáč · Chief Executive OfficerSource: business register
- Zuzana Slatkovská · HRSource: company website
More biotech & pharma companies
IBSA Slovakia
Pharmaceutical products for patients and healthcare professionals in SlovakiaProfitableINTEC PHARMA
Pharmaceutical distributor supplying medicines and medical devices to pharmacies and hospitals in SlovakiaProfitableNew on EvolcJUHAPHARM
Pharmaceutical distribution, product development and industrial R&D for healthcare and industry clientsProfitableNew on EvolcKRKA Slovensko
Generic prescription, over-the-counter and veterinary medicines sold in Slovakia by the local unit of a foreign pharma groupProfitableMagnaPharm SK
Pharmaceutical import, local distribution and support services for manufacturers and customers in SlovakiaProfitableGrowingNew on EvolcMediXbank, n.o.
Nonprofit biomedical research and biobanking for researchers and healthcare professionalsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Forms
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Tailwind CSSMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.